Cargando…

Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study

BACKGROUND: Although numerous studies and metanalysis have shown the beneficial effect of statin therapy in CVD secondary prevention, there is still controversy such the use of statins for primary CVD prevention in patients with DM. The purpose of this study was to evaluate the occurrence of total m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasso, Ferdinando Carlo, Lascar, Nadia, Ascione, Antonella, Carbonara, Ornella, De Nicola, Luca, Minutolo, Roberto, Salvatore, Teresa, Rizzo, Maria Rosaria, Cirillo, Plinio, Paolisso, Giuseppe, Marfella, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062846/ https://www.ncbi.nlm.nih.gov/pubmed/27733159 http://dx.doi.org/10.1186/s12933-016-0463-9

Ejemplares similares

Dipeptidyl Peptidase 4 Inhibition May Facilitate Healing of Chronic Foot Ulcers in Patients with Type 2 Diabetes
por: Marfella, Raffaele, et al.
Publicado: (2012)

Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of dipeptidyl peptidase-IV inhibition
por: Rizzo, Maria Rosaria, et al.
Publicado: (2012)

Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
por: Rizzo, Maria Rosaria, et al.
Publicado: (2013)

Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
por: Sardu, Celestino, et al.
Publicado: (2016)

Why do ineffective treatments seem helpful? A brief review
por: Hartman, Steve E
Publicado: (2009)

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2018)

Recommended rates of azoxystrobin and tebuconazole seem to be environmentally safe but ineffective against target fungi
por: Queirós, Libânia, et al.
Publicado: (2023)

Association of Genetic Variation in Adaptor Protein APPL1/APPL2 Loci with Non-Alcoholic Fatty Liver Disease
por: Barbieri, Michelangela, et al.
Publicado: (2013)

Mediterranean Diet, Telomere Maintenance and Health Status among Elderly
por: Boccardi, Virginia, et al.
Publicado: (2013)

Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients
por: Barbieri, Michelangela, et al.
Publicado: (2016)

Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome
por: Sardu, Celestino, et al.
Publicado: (2017)

The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes
por: Marfella, Raffaele, et al.
Publicado: (2007)

Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
por: Fontanella, Rosaria Anna, et al.
Publicado: (2021)

Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes
por: Sardu, Celestino, et al.
Publicado: (2017)

Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients
por: Rizzo, Maria Rosaria, et al.
Publicado: (2010)

Bariatric Surgery Reduces Oxidative Stress by Blunting 24-h Acute Glucose Fluctuations in Type 2 Diabetic Obese Patients
por: Marfella, Raffaele, et al.
Publicado: (2010)

Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
por: Tan, Roderick J., et al.
Publicado: (2013)

miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2021)

Corrigendum: miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2022)

Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
por: Sardu, Celestino, et al.
Publicado: (2018)

Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications
por: Marfella, Raffaele, et al.
Publicado: (2022)

ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial
por: Sardu, Celestino, et al.
Publicado: (2018)

Serum adiponectin levels are associated with worse cognitive function in postmenopausal women
por: De Franciscis, Pasquale, et al.
Publicado: (2017)

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
por: Sardu, Celestino, et al.
Publicado: (2021)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Hyperglycaemia on admission to hospital and COVID-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
por: Sardu, Celestino, et al.
Publicado: (2020)

Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
por: D'Onofrio, Nunzia, et al.
Publicado: (2021)

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2021)

Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Evidence for human diabetic cardiomyopathy
por: Marfella, Raffaele, et al.
Publicado: (2021)

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
por: Marfella, Raffaele, et al.
Publicado: (2021)

Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study
por: Sardu, Celestino, et al.
Publicado: (2020)

Overstimulated and ineffective
por: Van Epps, Heather L.
Publicado: (2005)

SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older People
por: Rizzo, Maria Rosaria, et al.
Publicado: (2021)

Implications of ABO blood group in hypertensive patients with covid-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Implications of AB0 blood group in hypertensive patients with covid-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023)

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
por: Nevola, Riccardo, et al.
Publicado: (2023)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0taofmv0jc4dld79bngi8bur1g